%0 Journal Article
%T Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit¨CRisk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA
%A Bj£¿rn Tackenberg
%A Christian Cornelissen
%A Christoph Lassek
%A Holger Albrecht
%A Jennie Medin
%A Judith Haas
%A Luisa Klotz
%A Michael Lang
%A Stephan Schmidt
%A Tjalf Ziemssen
%A on behalf of the PANGAEA study group
%J Archive of "Neurotherapeutics".
%D 2018
%R 10.1007/s13311-017-0595-y
%X The online version of this article (10.1007/s13311-017-0595-y) contains supplementary material, which is available to authorized users
%K Multiple sclerosis
%K Fingolimod
%K Real-world evidence
%K Benefit¨Crisk profile
%K Observational study
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794706/